Trial Profile
Influence of Liraglutide on Diastolic Cardiac Function and Myocardial Perfusion as Determined by Magnetic Resonance Imaging in Patients With Type 2 Diabetes: a Double-blind Randomized Parallel-group Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 06 Oct 2020 Status changed from active, no longer recruiting to completed.
- 08 Feb 2020 This trial is completed in Denmark (Global End Date: 1 Jan 2020), according to European Clinical Trials Database record.
- 12 Sep 2019 Planned End Date changed from 1 Jul 2019 to 1 Jun 2020.